Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 9, Number 5, August 2009


Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)
pp. 595-607(13)
Authors: Heffeter, P.; Popovic-Bijelic, A.; Saiko, P.; Dornetshuber, R.; Jungwirth, U.; Voevodskaya, N.; Biglino, D.; Jakupec, M. A.; Elbling, L.; Micksche, M.; Szekeres, T.; Keppler, B. K.; Graslund, A.; Berger, W.


Deacetylase Inhibitors Modulate the Myostatin/Follistatin Axis without Improving Cachexia in Tumor-Bearing Mice
pp. 608-616(9)
Authors: Bonetto, A.; Penna, F.; Minero, V. G.; Reffo, P.; Bonelli, G.; Baccino, F. M.; Costelli, P.


P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)
pp. 617-625(9)
Authors: Tripodo, C.; Florena, A. M.; Macor, P.; Di Bernardo, A.; Porcasi, R.; Guarnotta, C.; Ingrao, S.; Zerilli, M.; Secco, E.; Todaro, M.; Tedesco, F.; Franco, V.


The Role of Fibroblast Growth Factors in Tumor Growth
pp. 639-651(13)
Authors: Korc, M.; Friesel, R. E.


Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)
pp. 675-689(15)
Authors: Gleixner, K. V.; Mayerhofer, M.; Vales, A.; Gruze, A.; Hormann, G.; Cerny-Reiterer, S.; Lackner, E.; Hadzijusufovic, E.; Herrmann, H.; Iyer, A. K.; Krauth, M.-T.; Pickl, W. F.; Marian, B.; Panzer-Grumayer, R.; Sillaber, C.; Maeda, H.; Zielinski, C.; Valent, P.


Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
pp. 690-704(15)
Authors: Caraglia, M.; Marra, M.; Tagliaferri, P.; Lamberts, S. W.J.; Zappavigna, S.; Misso, G.; Cavagnini, F.; Facchini, G.; Abbruzzese, A.; Hofland, L. J.; Vitale, G.


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more